The mysterious condition may be wide-reaching Published 11/02/23, Mansur Shaheen, The Messenger Upwards of 50 million Americans could have experienced symptoms of long COVID at some point in the last three years, according to a new study. Researchers at the University College London, in England, gathered data from 461,550 people who completed a U.S. Census […]
There is no cure or approved treatment for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). However, some symptoms can be treated or managed. Treating these symptoms might provide relief for some patients with ME/CFS but not others. Other strategies, like learning new ways to manage activity, can also be helpful. Patients, their families, and healthcare providers need […]
Dominique Comeau1† Mykella Martin2† Gilles A. Robichaud3,4,5 Ludivine Chamard-Witkowski2,6*1Dr. Georges-L. Long COVID syndrome, also known as post-acute sequelae of COVID-19 (PASC), is characterized by persistent symptoms lasting 3–12 weeks post SARS-CoV-2 infection. Patients suffering from PASC can display a myriad of symptoms that greatly diminish quality of life, the most frequent being neuropsychiatric. Thus, there is an eminent need […]
January 5, 2023 Authors: Jakke Tamminen, Rebecca Crowley https://theconversation.com/us By the end of 2022, more than 650 million COVID infections had been reported to the World Health Organization. With the true number likely much higher, and the tally increasing by hundreds of thousands every week, the scientific community has been focused on understanding the impact of […]
September 13, 2023 Dr. Anis Rehman Internal Medicine Physician The Sleep Foundation Key Takeaways Even years after the declaration of a global pandemic in March 2020, studies continue to document the effects of COVID-19, the disease caused by the SARS-CoV-2 coronavirus. A growing body of evidence demonstrates that COVID-19 can cause both short- and long-term View Source sleep […]
Authors: Jocelyn Solis-Moreira JUNE 20, 2022 https://www.braintomorrow.com/ People continue to experience neurological problems six months after recovering from a COVID-19 infection, finds a recent study from the University of California San Diego. In fact, scientists say most coronavirus long-haulers battle brain-related issues. The findings are part of a long-term study tracking the progression of neurological […]
Authors: Anne Gardner1, Jennifer Debenham1, Nicola Clare Newton1, Cath Chapman Fiona Elizabeth Wylie2, Bridie Osman1, Maree Teesson, Katrina Elizabeth Champion The British Medical Journal Abstract Objective To examine changes in the prevalence of six key chronic disease risk factors (the “Big 6”), from before (2019) to during (2021) the COVID-19 pandemic, among a large and geographically diverse sample of adolescents, and […]
Authors: AdamHampshireaDoris A.ChatfieldbAnne ManktelowMPhilbAmyJollyaWilliamTrenderaPeter J.HellyeraMartina DelGiovaneaVirginia F.J.NewcombebJoanne G. Outtrimb BenWarneb JunaidBhattid LindaPointond AnneElmere NyarieSitholebf JohnBradleybgh NathalieKingston lStephen J.Sawceri Edward T.Bullmorecdj…David K.Menonbck1 Volume 47, May 2022, 101417 Summary Background Preliminary evidence has highlighted a possible association between severe COVID-19 and persistent cognitive deficits. Further research is required to confirm this association, determine whether cognitive deficits relate to clinical […]
Authors: Chris Melore Study Finds May 3, 2022 A severe coronavirus infection could leave patients with the brain of a 70-year-old, lowering someone’s IQ by 10 points, according to a new study. Researchers from the University of Cambridge and Imperial College London found that COVID patients are dealing with levels of cognitive impairment which are […]
Authors: Steve Reiken,Leah Sittenfeld,Haikel Dridi,Yang Liu,Xiaoping Liu,Andrew R. Marks First published: 03 February 2022 https://doi.org/10.1002/alz.12558 Abstract Introduction The mechanisms that lead to cognitive impairment associated with COVID-19 are not well understood. Methods Brain lysates from control and COVID-19 patients were analyzed for oxidative stress and inflammatory signaling pathway markers, and measurements of Alzheimer’s disease (AD)-linked […]
